1
Fulvio Foschini, Marcello Stagni, Giulio Luciani, Pierre Roy: Cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus. SOOFT ITALIA, Young & Thompson, September 13, 2016: US09439908

An improved formulation of an ophthalmic composition contains riboflavin, as cross-linking agent of corneal collagen, administered by corneal iontophoresis, able to guarantee an increased capacity of permeation of riboflavin of the corneal stroma and therefore greater therapeutic efficacy in the tre ...


2
Marcello STAGNI, Edoardo STAGNI, Massimo FILIPPELLO, Giovanni CAVALLO, Eugenio SODO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. Sooft Italia, June 23, 2011: US20110152219-A1

The use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by the method of corneal cross-linking.



Click the thumbnails below to visualize the patent trend.